Trastuzumab Deruxtecan for Breast Cancer

N Engl J Med. 2022 Jun 16;386(24):2346-2347. doi: 10.1056/NEJMc2205309.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Ado-Trastuzumab Emtansine
  • Breast Neoplasms* / drug therapy
  • Camptothecin / analogs & derivatives
  • Female
  • Humans
  • Immunoconjugates*
  • Trastuzumab / therapeutic use

Substances

  • Immunoconjugates
  • trastuzumab deruxtecan
  • Trastuzumab
  • Ado-Trastuzumab Emtansine
  • Camptothecin